Title | Type | SJR | H index | Total Docs. (2022) | Total Docs. (3years) | Total Refs. (2022) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2022) | %Female (2022) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Cell Stem Cell | journal | 9.156 Q1 | 305 | 153 | 581 | 8860 | 8716 | 503 | 14.77 | 57.91 | 42.53 | |
2 | Pharmacological Reviews | journal | 5.338 Q1 | 254 | 37 | 87 | 12754 | 1865 | 87 | 21.58 | 344.70 | 39.80 | |
3 | Molecular Therapy | journal | 3.425 Q1 | 209 | 292 | 731 | 16360 | 7208 | 643 | 9.27 | 56.03 | 42.46 | |
4 | Medicinal Research Reviews | journal | 2.748 Q1 | 150 | 63 | 250 | 12505 | 3621 | 245 | 14.08 | 198.49 | 44.66 | |
5 | Cell Chemical Biology | journal | 2.541 Q1 | 206 | 157 | 503 | 8654 | 3750 | 471 | 7.39 | 55.12 | 39.32 | |
6 | Molecular Therapy - Nucleic Acids | journal | 1.947 Q1 | 95 | 292 | 963 | 16402 | 8540 | 959 | 8.54 | 56.17 | 41.35 | |
7 | Human Genetics and Genomics Advances | journal | 1.920 Q1 | 13 | 75 | 35 | 4087 | 142 | 34 | 4.06 | 54.49 | 52.97 | |
8 | Molecular Therapy - Methods and Clinical Development | journal | 1.825 Q1 | 60 | 164 | 589 | 8119 | 3050 | 587 | 4.94 | 49.51 | 47.06 | |
9 | Journal of Medicinal Chemistry | journal | 1.805 Q1 | 301 | 904 | 2616 | 60242 | 19146 | 2592 | 7.19 | 66.64 | 37.46 | |
10 | Clinical and Translational Medicine | journal | 1.706 Q1 | 18 | 38 | 59 | 1817 | 279 | 25 | 4.81 | 47.82 | 39.48 | |
11 | Nucleic Acid Therapeutics | journal | 1.490 Q1 | 77 | 46 | 118 | 2358 | 481 | 115 | 3.97 | 51.26 | 37.31 | |
12 | ACS Chemical Biology | journal | 1.369 Q1 | 135 | 339 | 956 | 15698 | 4113 | 949 | 3.98 | 46.31 | 37.44 | |
13 | Stem Cells | journal | 1.339 Q1 | 253 | 94 | 431 | 5885 | 2123 | 411 | 4.82 | 62.61 | 42.53 | |
14 | Molecular Medicine | journal | 1.245 Q1 | 133 | 162 | 333 | 9799 | 1921 | 331 | 5.46 | 60.49 | 41.93 | |
15 | BioFactors | journal | 1.139 Q2 | 113 | 86 | 235 | 6718 | 1522 | 231 | 6.65 | 78.12 | 42.20 | |
16 | NeuroMolecular Medicine | journal | 1.069 Q2 | 82 | 47 | 147 | 2241 | 700 | 146 | 4.00 | 47.68 | 41.91 | |
17 | Molecular Pharmacology | journal | 1.061 Q2 | 210 | 68 | 347 | 4271 | 1269 | 343 | 3.45 | 62.81 | 35.95 | |
18 | Human Gene Therapy | journal | 1.045 Q2 | 159 | 132 | 446 | 5597 | 1486 | 389 | 2.92 | 42.40 | 44.17 | |
19 | SLAS Discovery | journal | 1.042 Q2 | 33 | 56 | 318 | 1177 | 961 | 298 | 3.04 | 21.02 | 38.21 | |
20 | Cancer Biology and Therapy | journal | 0.996 Q2 | 130 | 64 | 356 | 2710 | 1604 | 354 | 3.28 | 42.34 | 38.20 | |
21 | Journal of Pharmacology and Experimental Therapeutics | journal | 0.972 Q2 | 244 | 105 | 604 | 4213 | 2333 | 600 | 3.31 | 40.12 | 41.94 | |
22 | Vascular Pharmacology | journal | 0.952 Q2 | 108 | 71 | 195 | 3832 | 875 | 191 | 3.72 | 53.97 | 44.40 | |
23 | Molecular Pharmaceutics | journal | 0.929 Q2 | 156 | 401 | 1232 | 22556 | 6582 | 1225 | 5.02 | 56.25 | 38.95 | |
24 | Journal of Natural Products | journal | 0.902 Q2 | 161 | 295 | 1182 | 11577 | 5844 | 1171 | 5.11 | 39.24 | 37.93 | |
25 | Nanomedicine: Nanotechnology, Biology, and Medicine | journal | 0.899 Q2 | 151 | 136 | 551 | 6898 | 3321 | 549 | 5.72 | 50.72 | 45.92 | |
26 | Cold Spring Harbor molecular case studies | journal | 0.854 Q2 | 25 | 71 | 197 | 2059 | 439 | 195 | 1.70 | 29.00 | 48.52 | |
27 | Journal of Cardiovascular Translational Research | journal | 0.853 Q2 | 60 | 131 | 300 | 5557 | 1068 | 279 | 3.51 | 42.42 | 37.38 | |
28 | Probiotics and Antimicrobial Proteins | journal | 0.804 Q2 | 52 | 98 | 451 | 6945 | 2601 | 451 | 5.21 | 70.87 | 45.89 | |
29 | Human gene therapy methods | journal | 0.780 Q2 | 38 | 0 | 24 | 0 | 87 | 24 | 0.00 | 0.00 | 0.00 | |
30 | Journal of Experimental Zoology Part B: Molecular and Developmental Evolution | journal | 0.755 Q2 | 70 | 57 | 146 | 3508 | 265 | 118 | 1.92 | 61.54 | 38.89 | |
31 | Blood Cells, Molecules, and Diseases | journal | 0.718 Q3 | 98 | 27 | 241 | 828 | 459 | 198 | 1.90 | 30.67 | 44.97 | |
32 | Molecular Imaging | journal | 0.697 Q3 | 66 | 21 | 56 | 902 | 188 | 56 | 2.59 | 42.95 | 40.40 | |
33 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.663 Q3 | 29 | 7 | 24 | 608 | 185 | 7 | 7.64 | 86.86 | 0.00 | |
34 | Journal of Gene Medicine | journal | 0.657 Q3 | 100 | 57 | 273 | 2577 | 943 | 268 | 3.44 | 45.21 | 40.68 | |
35 | Pharmaceutical Research | journal | 0.644 Q3 | 229 | 234 | 581 | 13222 | 2258 | 568 | 3.53 | 56.50 | 34.87 | |
36 | Journal of Biochemical and Molecular Toxicology | journal | 0.627 Q3 | 69 | 274 | 638 | 14888 | 2353 | 637 | 3.64 | 54.34 | 44.97 | |
37 | OMICS A Journal of Integrative Biology | journal | 0.602 Q3 | 69 | 67 | 241 | 3411 | 687 | 193 | 3.02 | 50.91 | 44.52 | |
38 | Viral Immunology | journal | 0.559 Q3 | 70 | 86 | 261 | 3685 | 483 | 218 | 1.77 | 42.85 | 47.29 | |
39 | Nuclear Medicine and Biology | journal | 0.512 Q3 | 98 | 65 | 196 | 2647 | 566 | 190 | 3.03 | 40.72 | 36.43 | |
40 | Pharmacogenetics and Genomics | journal | 0.486 Q3 | 152 | 40 | 87 | 1553 | 196 | 84 | 2.61 | 38.83 | 43.43 | |
41 | Biotechnology and Applied Biochemistry | journal | 0.467 Q3 | 81 | 240 | 359 | 14045 | 1113 | 354 | 3.01 | 58.52 | 42.63 | |
42 | Chemistry and Biodiversity | journal | 0.380 Q4 | 83 | 498 | 850 | 22452 | 2585 | 847 | 2.96 | 45.08 | 43.15 | |
43 | Assay and Drug Development Technologies | journal | 0.358 Q4 | 65 | 34 | 128 | 1424 | 265 | 120 | 1.78 | 41.88 | 39.47 | |
44 | Nucleosides, Nucleotides and Nucleic Acids | journal | 0.254 Q4 | 53 | 81 | 224 | 2783 | 342 | 224 | 1.47 | 34.36 | 38.72 | |
45 | MCB Molecular and Cellular Biomechanics | journal | 0.180 Q4 | 31 | 20 | 88 | 533 | 47 | 82 | 0.54 | 26.65 | 39.29 | |
46 | Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry | journal | 0.159 Q4 | 16 | 37 | 119 | 1635 | 67 | 119 | 0.65 | 44.19 | 57.67 | |
47 | OBM Genetics | journal | 0.153 Q4 | 4 | 27 | 84 | 1822 | 23 | 77 | 0.22 | 67.48 | 60.22 | |
48 | Forum on Immunopathological Diseases and Therapeutics | journal | 0.107 Q4 | 14 | 0 | 9 | 0 | 1 | 9 | 0.11 | 0.00 | 0.00 | |
49 | Journal of Stem Cells | journal | 0.102 Q4 | 21 | 4 | 37 | 651 | 2 | 36 | 0.07 | 162.75 | 66.67 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®